A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell RecognitionW.A. Macdonald, James McCluskey, Anthony W. Purcell et al.|The Journal of Experimental Medicine|2003Cited by 209
Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Koert J. Stittelaar et al.|Clinical & Translational Immunology|2021Cited by 62
Development of Novel Activin-Targeted TherapeuticsJustin L. Chen, Craig A. Harrison, Kelly L. Walton et al.|Molecular Therapy|2014Cited by 57
Activin A–Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male MiceKelly L. Walton, Craig A. Harrison, Justin L. Chen et al.|Endocrinology|2019Cited by 22
Rapid Application of the Molecular Clamp Platform for SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|SSRN Electronic Journal|2020Cited by 1